Brighton Ashford has been providing expertise to life sciences industry clients since 2015.

You and the pharmaceutical and medical device markets rely on the third-party testing industry for quality assurance and FDA approval. Since 2024, the FDA has noted a dramatic increase in fraud in this market.

If you are working within or want to enter the pharmaceutical or medical device supply chains, book some FREE time with us HERE.

Understanding the third-party testing regulatory and legal landscape can seem impossible and mistakes can be costly. Leverage our experience and expertise to help you mitigate risk by turning unknowns into knowns.